Les Sulewski's Stock Ratings

Truist Securities Analyst

Les Sulewski is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/29/2025

Overall Average Return

-36.4%

Smart Score

20.1%

Overall Average Return Percentile

5th

Number of Ratings

11
Buy NowGet Alert
01/30/2025PCRXBuy Now
Pacira BioSciences
$27.00-7.41%
Les Sulewski20%
$8 → $25UpgradeSell → HoldGet Alert
10/02/2024AMRXBuy Now
Amneal Pharmaceuticals
$7.7554.84%
Les Sulewski20%
$10 → $12MaintainsBuyGet Alert
08/13/2024PCRXBuy Now
Pacira BioSciences
$27.00-70.37%
Les Sulewski20%
$30 → $8DowngradeBuy → SellGet Alert
08/12/2024AMRXBuy Now
Amneal Pharmaceuticals
$7.7529.03%
Les Sulewski20%
$9 → $10MaintainsBuyGet Alert
08/09/2024COLLBuy Now
Collegium Pharmaceutical
$27.6052.17%
Les Sulewski20%
$40 → $42MaintainsBuyGet Alert
07/25/2024PCRXBuy Now
Pacira BioSciences
$27.0011.11%
Les Sulewski20%
$45 → $30MaintainsBuyGet Alert
07/02/2024PCRXBuy Now
Pacira BioSciences
$27.0066.67%
Les Sulewski20%
$45 → $45ReiteratesBuy → BuyGet Alert
05/06/2024AMRXBuy Now
Amneal Pharmaceuticals
$7.7516.13%
Les Sulewski20%
$7 → $9ReiteratesBuy → BuyGet Alert
02/26/2024COLLBuy Now
Collegium Pharmaceutical
$27.6044.93%
Les Sulewski20%
$37 → $40MaintainsBuyGet Alert
11/02/2023PCRXBuy Now
Pacira BioSciences
$27.0066.67%
Les Sulewski20%
$50 → $45MaintainsBuyGet Alert
08/03/2023PCRXBuy Now
Pacira BioSciences
$27.00103.7%
Les Sulewski20%
$60 → $55MaintainsBuyGet Alert